FA
KIDS icon

Friess Associates’s OrthoPediatrics KIDS Stock Holding History

Friess Associates’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-92,140
Closed -$4.33M – 125
2019
Q4 		$4.33M Buy
+92,140
New +$3.57M 0.3% 85

Other funds holding KIDS

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Friess Associates's KIDS Position: Q1 2020 in Review

Friess Associates sold out of OrthoPediatrics (KIDS) in Q1 2020, closing a stake of 92,140 shares — an estimated $4.33M sold.

Friess Associates first reported a position in KIDS in Q4 2019 and held it in 1 quarter. The position peaked at $4.33M in Q4 2019. 106 funds tracked by Wall St. Rank hold KIDS as of Q1 2020.

  • Friess Associates reported no remaining OrthoPediatrics position as of Q1 2020 after selling out during the quarter.
  • Friess Associates sold 92,140 OrthoPediatrics shares in Q1 2020, an estimated $4.33M.
  • Friess Associates first reported a position in OrthoPediatrics in Q4 2019 and held it in 1 quarter.
  • Friess Associates's OrthoPediatrics position peaked at $4.33M in Q4 2019.
  • 106 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2020.

Based on Friess Associates's 13F filing for Q1 2020, filed 15 May 2020.